Get started
Author

Isabella Comello

Observed names: COMELLO, ISABELLA, I. Comello
ORCID: 0009-0004-4732-9775
Observed ORCID: 0009-0004-4732-9775
OpenAlex ID: A5036519112
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
2021 · Carla Colombo, Marco Cipolli, et al. · Infection · 28
PDF
Long-term clinical outcomes of elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis and advanced pulmonary disease
2023 · Daniela Savi, Francesca Lucca, et al. · Respiratory Medicine · 13
PDF
COVID-19 in people with Cystic Fibrosis beyond the pre-omicron era: a prospective study with a specific focus on long COVID
2025 · Carla Colombo, Paola Medino, et al. · Journal of Cystic Fibrosis
P159 Long COVID in people with cystic fibrosis: a prospective observational study within the Italian Cystic Fibrosis Society
2025 · C. Colombo, P. Medino, et al. · Journal of Cystic Fibrosis
P081 Comparative analysis of CFTR modulators: unravelling the impact on radiological and clinical outcomes
2024 · I. Comello, F. Lucca, et al. · Journal of Cystic Fibrosis
ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
2022 · F. Lucca, V. Carnovale, et al. · Journal of Cystic Fibrosis
PDF
P053 Real-life clinical effects of therapy with lumacaftor and ivacaftor in patients with cystic fibrosis
2021 · I. Comello, F. Lucca, et al. · Journal of Cystic Fibrosis
Works count: 8
Citation count: 41
H-index: 2
I10-index: 2
Year
Topic
Type